药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Metrizamide
Magnesium aspartate
Magnesium aspartate can cause a decrease in the absorption of Calcium phosphate dihydrate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Metrizamide
Hydrotalcite
Hydrotalcite can cause a decrease in the absorption of Calcium phosphate dihydrate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Metrizamide
Magnesium chloride
Magnesium chloride can cause a decrease in the absorption of Calcium phosphate dihydrate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Metrizamide
Magaldrate
Magaldrate can cause a decrease in the absorption of Calcium phosphate dihydrate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Metrizamide
Calcium polycarbophil
Calcium polycarbophil can cause a decrease in the absorption of Calcium phosphate dihydrate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Metrizamide
Calcium pangamate
Calcium pangamate can cause a decrease in the absorption of Calcium phosphate dihydrate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Metrizamide
Calcium lactate gluconate
Calcium lactate gluconate can cause a decrease in the absorption of Calcium phosphate dihydrate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Metrizamide
Calcium lactate
Calcium lactate can cause a decrease in the absorption of Calcium phosphate dihydrate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Metrizamide
Calcium gluconate
Calcium gluconate can cause a decrease in the absorption of Calcium phosphate dihydrate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Metrizamide
Calcium carbonate
Calcium carbonate can cause a decrease in the absorption of Calcium phosphate dihydrate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Attapulgite
Satralizumab
The serum concentration of Tenofovir can be decreased when it is combined with Satralizumab.
Attapulgite
Abametapir
The serum concentration of Tenofovir can be increased when it is combined with Abametapir.
Attapulgite
Cenobamate
The serum concentration of Tenofovir can be decreased when it is combined with Cenobamate.
Attapulgite
Polymyxin B
The risk or severity of adverse effects can be increased when Tenofovir is combined with Polymyxin B.
Attapulgite
Belantamab mafodotin
The serum concentration of Belantamab mafodotin can be increased when it is combined with Tenofovir.
Attapulgite
Berotralstat
The serum concentration of Berotralstat can be increased when it is combined with Tenofovir.
Attapulgite
Remdesivir
The serum concentration of Remdesivir can be increased when it is combined with Tenofovir.
Attapulgite
Ubrogepant
The serum concentration of Ubrogepant can be increased when it is combined with Tenofovir.
Attapulgite
Larotrectinib
The serum concentration of Larotrectinib can be increased when it is combined with Tenofovir.
Attapulgite
Binimetinib
The serum concentration of Binimetinib can be increased when it is combined with Tenofovir.